1,828
Views
21
CrossRef citations to date
0
Altmetric
Editorial

Angiotensin II type 2 receptor agonists – where should they be applied?

, MD PhD & , MD PhD
Pages 763-766 | Published online: 21 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Marco Cascella, Alfredo Del Gaudio, Alessandro Vittori, Sabrina Bimonte, Paola Del Prete, Cira Antonietta Forte, Arturo Cuomo & Elvio De Blasio. (2021) COVID-Pain: Acute and Late-Onset Painful Clinical Manifestations in COVID-19 – Molecular Mechanisms and Research Perspectives. Journal of Pain Research 14, pages 2403-2412.
Read now
Maree T Smith & Arjun Muralidharan. (2015) Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain. Expert Opinion on Therapeutic Targets 19:1, pages 25-35.
Read now

Articles from other publishers (19)

Gabriel Méndez-Valdés, Vicente Pérez-Carreño, Maria Chiara Bragato, Malthe Hundahl, Silvia Chichiarelli, Luciano Saso & Ramón Rodrigo. (2022) Cardioprotective Mechanisms against Reperfusion Injury in Acute Myocardial Infarction: Targeting Angiotensin II Receptors. Biomedicines 11:1, pages 17.
Crossref
Marco Cascella & Elvio De BlasioMarco Cascella & Elvio De Blasio. 2022. Features and Management of Acute and Chronic Neuro-Covid. Features and Management of Acute and Chronic Neuro-Covid 1 41 .
Rodrigo Barbosa de Souza, Elisa Ito Kawahara, Luis Ernesto Farinha-Arcieri, Isabela Gerdes Gyuricza, Bianca Neofiti-Papi, Manuela Miranda-Rodrigues, Marilia Bianca Cruz Grecco Teixeira, Gustavo Ribeiro Fernandes, Renan Barbosa Lemes, Dieter P. Reinhardt, Cecília Helena Gouveia & Lygia V. Pereira. (2021) Hyperkyphosis is not dependent on bone mass and quality in the mouse model of Marfan syndrome. Bone 152, pages 116073.
Crossref
Tianxin Yang. (2021) Targeting angiotensin AT2 receptors in renal disease. American Journal of Physiology-Renal Physiology.
Crossref
Massimo Volpe & Speranza Rubattu. 2019. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases 483 489 .
Laura Sabatino, Chiara Costagli, Dominga Lapi, Cristina Del Seppia, Giuseppe Federighi, Silvana Balzan, Antonio Colantuoni, Giorgio Iervasi & Rossana Scuri. (2018) Renin-Angiotensin System Responds to Prolonged Hypotensive Effect Induced by Mandibular Extension in Spontaneously Hypertensive Rats. Frontiers in Physiology 9.
Crossref
Peter Verbrugghe, Jelle Verhoeven, Marnick Clijsters, Dominique Vervoort, Jarne Schepens, Bart Meuris & Paul Herijgers. (2018) The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome. Journal of Cardiovascular Pharmacology 71:4, pages 215-222.
Crossref
Johan Wannberg, Rebecka Isaksson, Ulf Bremberg, Maria Backlund, Jonas Sävmarker, Mathias Hallberg & Mats Larhed. (2018) A convenient transesterification method for synthesis of AT2 receptor ligands with improved stability in human liver microsomes. Bioorganic & Medicinal Chemistry Letters 28:3, pages 519-522.
Crossref
Robson Veras, Darizy Silva, Lorena Bezerra, Valéria Assis, Walma Vasconcelos, Maria Alustau, José Albuquerque, Fabíola Furtado, Islania Araújo, Fátima Azevedo, Thais Ribeiro, José Barbosa-Filho, Stanley Gutierrez & Isac Medeiros. (2018) N-Salicyloyltryptamine, an N-Benzoyltryptamine Analogue, Induces Vasorelaxation through Activation of the NO/sGC Pathway and Reduction of Calcium Influx. Molecules 23:2, pages 253.
Crossref
Sonia Villapol, María G. Balarezo, Kwame Affram, Juan M. Saavedra & Aviva J. Symes. (2015) Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Brain 138:11, pages 3299-3315.
Crossref
Francisco Westermeier, Mario Bustamante, Mario Pavez, Lorena García, Mario Chiong, María Paz Ocaranza & Sergio Lavandero. (2015) Novel players in cardioprotection: Insulin like growth factor-1, angiotensin-(1–7) and angiotensin-(1–9). Pharmacological Research 101, pages 41-55.
Crossref
Mathias Hallberg. (2015) Neuropeptides: Metabolism to Bioactive Fragments and the Pharmacology of Their Receptors. Medicinal Research Reviews 35:3, pages 464-519.
Crossref
Andrew S C Rice, Robert H Dworkin, Tom D McCarthy, Praveen Anand, Chas Bountra, Philip I McCloud, Julie Hill, Gary Cutter, Geoff Kitson, Nuket Desem & Milton Raff. (2014) EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial. The Lancet 383:9929, pages 1637-1647.
Crossref
Pawel Namsolleck, Chiara Recarti, Sébastien Foulquier, Ulrike Muscha Steckelings & Thomas Unger. (2014) AT2 Receptor and Tissue Injury: Therapeutic Implications. Current Hypertension Reports 16:2.
Crossref
Jean-Baptiste Veron, Advait Joshi, Charlotta Wallinder, Mats Larhed & Luke R. Odell. (2014) Synthesis and evaluation of isoleucine derived angiotensin II AT2 receptor ligands. Bioorganic & Medicinal Chemistry Letters 24:2, pages 476-479.
Crossref
Ross G Douglas, Mario R Ehlers & Edward D Sturrock. (2013) Antifibrotic peptide N -acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): Opportunities for angiotensin-converting enzyme inhibitor design . Clinical and Experimental Pharmacology and Physiology 40:8, pages 535-541.
Crossref
Roman Hafko, Sonia Villapol, Regina Nostramo, Aviva Symes, Esther L. Sabban, Tadashi Inagami & Juan M. Saavedra. (2013) Commercially Available Angiotensin II At2 Receptor Antibodies Are Nonspecific. PLoS ONE 8:7, pages e69234.
Crossref
Rodrigo Araujo Fraga-Silva, Anderson Jose Ferreira & Robson Augusto Souza dos Santos. (2012) Opportunities for Targeting the Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Pathway in Hypertension. Current Hypertension Reports 15:1, pages 31-38.
Crossref
Michaël ShumSandra PinardMarie-Odile GuimondSébastien M. LabbéClaude RobergeJean-Patrice BaillargeonMarie-France LangloisMathias Alterman, Charlotta Wallinder, Anders Hallberg, André C. CarpentierNicole Gallo-Payet. (2013) Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. American Journal of Physiology-Endocrinology and Metabolism 304:2, pages E197-E210.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.